PATENT CLAIM ANALYSIS

Application Number: 15861017
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "259000"]

Abstract:
A method of treating a pediatric cancer in a subject in need thereof. The method includes administering to the subject a therapeutically effective amount of (S)—N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, or a pharmaceutically acceptable salt thereof, or a combination thereof.

Claim (Index 22):
The method of  claim 18 , wherein the crystalline form is characterized by having XRPD diffraction peaks (2\u03b8 degrees) at 10.7\u00b10.2, 15.3\u00b10.2, 16.5\u00b10.2, 18.4\u00b10.2, 19.2\u00b10.2, 19.9\u00b10.2, 20.2\u00b10.2, 20.7\u00b10.2, 21.5\u00b10.2, 22.1\u00b10.2, 23.1\u00b10.2, 24.0\u00b10.2. 24.4\u00b10.2, 25.6\u00b10.2, 26.5\u00b10.2, 27.6\u00b10.2, 28.2\u00b10.2, 28.7\u00b10.2, 30.8\u00b10.2, and 38.5\u00b10.2.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.5122
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15622388', '15622544', '15399207', '15706062', '15785228']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8108759305941673
- 35 USC 102 Novelty (BERT): 0.6367844994568177
- Combined Prediction Score: 0.7934667874804323
- Mean Citation Score: 432.988974
- Max Citation Score: 603.2879
- Similarity Product: 541.435522913909

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test